Abstracts
Résumé
Une des stratégies majeures mises en jeu par la peau pour se protéger des infections est de maintenir une barrière physique cutanée intacte. La désquamation, de même que la sécrétion de mucus, sont à l’origine d’un renouvellement permanent de la surface cutanée, qui s’accompagne d’une élimination des micro-organismes adhérant à cette surface. La découverte récente de peptides antibiotiques épithéliaux suggère qu’il existe, à côté de cette barrière physique, une barrière cutanée « chimique » constituée par des peptides antibiotiques capables de contrôler la croissance bactérienne au niveau des couches cutanées et, éventuellement, de lutter contre les infections.
Summary
Human skin is always in contact with the environment and is covered with a characteristic microflora, but it is usually not infected. Although desquamation and secretion of mucus lead to a permanent renewal of these body surfaces and simultaneous elimination of microorganisms adhering to these layers, another reason for this natural resistance might be the existence of a “chemical barrier” consisting in constitutively and inducibly produced antimicrobial peptides and proteins (AMPs), which include some ß-defensins, RNase 7, the S100-protein psoriasin and the cathelicidin LL-37. Most of these AMPs can be induced in vitro in epithelial cells by proinflammatory cytokines or bacteria. In vivo, AMPs are mainly expressed in uppermost and differentiated parts of inflammatory lesions and wounds, but some are also focally expressed in skin in the absence of inflammation, suggesting that apart from inflammatory mediators, also non-inflammatory stimuli of endogenous and/or exogenous origin can stimulate AMP-synthesis. Increased levels of AMPs in psoriatic lesions may explain why psoriasis patients rarely suffer from skin infections. Further, an increased infection rate in atopic dermatitis patients could be the consequence of decreased levels of AMPs in atopic lesions. These observations may indicate an important role of the “chemical skin barrier” in prevention of skin infection and suggest that artificial stimulation of this system, without inflammation, would be beneficial as « immune stimulus ».
Appendices
Références
- 1. Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol 2005 ; 125 : 183-200.
- 2. Ogawa H, Miyazaki H, Kimura M. Isolation and characterization of human skin lysozyme. J Invest Dermatol 1971 ; 57 : 111-6.
- 3. Harder J, Schröder JM. RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 2002 ; 277 : 46779-84.
- 4. Casewell MW, Desai N. Survival of multiply-resistant Klebsiella aerogenes and other gram negative bacilli on finger-tips. J Hosp Infect 1983 ; 4 : 350-60.
- 5. Gläser R, Harder J, Lange H, et al. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005 ; 6 : 57-64.
- 6. Schittek B, Hipfel R, Sauer B, et al. Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol 2001 ; 2 : 1133-7.
- 7. Harder J, Bartels J, Christophers E, et al. A peptide antibiotic from human skin. Nature 1997 ; 387 : 861
- 8. Harder J, Schröder JM. Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol 2005 ; 77 : 476-86
- 9. Harder J, Meyer-Hoffert U, Teran LM, et al. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 2000 ; 22 : 714-21
- 10. Ali RS, Falconer A, Ikram M, et al. Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. J Invest Dermatol 2001 ; 117 : 106-11.
- 11. Harder J, Meyer-Hoffert U, Wehkamp K, et al. Differential gene induction of human beta-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid. J Invest Dermatol 2004 ; 123 : 522-9.
- 12. Becker MN, Diamond G, Verghese MW, et al. CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem 2000; 275: 29731-36.
- 13. Sörensen OE, Thapa DR, Rosenthal A, et al. Differential regulation of β-defensin expression in human skin by microbial stimuli. J Immunol 2005 ; 174 : 4870-9.
- 14. Liu L, Roberts AA, Ganz T. By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol 2003 ; 170 : 575-80.
- 15. Krisanaprakornkit S, Kimball JR, Weinberg A, et al. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun 2000 ; 68 : 2907-15.
- 16. Chung WO, Dale BA. Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect Immun 2004 ; 72 : 352-8.
- 17. Harder J, Bartels J, Christophers E, et al. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001 ; 276 : 5707-13.
- 18. Garcia JR, Jaumann F, Schulz S, et al. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res 2001 ; 306 : 257-64.
- 19. Agerberth B, Gunne H, Odeberg J, et al. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 1995 ; 92 : 195-9.
- 20. Zanetti M. The role of cathelicidins in the innate host defenses of mammals. Curr Issues Mol Biol 2005 ; 7 : 179-96.
- 21. Frohm M, Agerberth B, Ahangari G, et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997 ; 272 : 15258-63.
- 22. Murakami M, Ohtake T, Dorschner RA, et al. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol 2002 ; 119 : 1090-5.
- 23. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 2005 ; 19 : 1067-77.
- 24. Nizet V, Ohtake T, Lauth X, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001 ; 414 : 454-7.
- 25. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995 ; 32 : 982-6
- 26. Nomura I, Goleva E, Howell MD, et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003 ; 171 : 3262-9.
- 27. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002 ; 347 : 1151-60.
- 28. Giesbrecht P, Kersten T, Maidhof H, Wecke J. Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol Mol Biol Rev 1998 ; 62 : 1371-1414.